Activation of glycolysis and apoptosis in glycogen storage disease type Ia

被引:17
|
作者
Sun, Baodong [1 ]
Li, Songtao [1 ]
Yang, Liu [2 ]
Damodaran, Tirupapuliyur [1 ]
Desai, Dev [3 ]
Diehl, Anna Mae [2 ]
Alzate, Oscar [4 ]
Koeberl, Dwight D. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA
[3] Childrens Med Ctr, Dept Surg, Dallas, TX 75235 USA
[4] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA
关键词
Glucose-6-phosphatase; von Gierke disease; Inherited disorder of metabolism; Glyceraldehyde-3-phosphate dehydrogenase; Apoptosis; Glycogen storage disease; Fatty liver; Gene therapy; HUMAN HEPATOCELLULAR-CARCINOMA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; NUCLEAR TRANSLOCATION; LIVER; PROTEIN; THERAPY; MICE; IDENTIFICATION; DYSFUNCTION; EXPRESSION;
D O I
10.1016/j.ymgme.2009.04.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The deficiency of glucose-6-phosphatase (G6Pase) underlies glycogen storage disease type Ia (GSD-Ia, von Gierke disease; MIM 232200), an autosomal recessive disorder of metabolism associated with life-threatening hypoglycemia, growth retardation, renal failure, hepatic adenomas, and hepatocellular carcinoma. Liver involvement includes the massive accumulation of glycogen and lipids due to accumulated glucose-6-phosphate and glycolytic intermediates. Proteomic analysis revealed elevations in glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and other enzymes involved in glycolysis. GAPDH was markedly increased in murine G6Pase-deficient hepatocytes. The moonlighting role of GAPDH includes increasing apoptosis, which was demonstrated by increased TUNEL assay positivity and caspase 3 activation in the murine GSD-Ia liver. These analyses of hepatic involvement in GSD-Ia mice have implicated the induction of apoptosis in the pathobiology of GSD-Ia. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:267 / 271
页数:5
相关论文
共 50 条
  • [1] Pregnancies in glycogen storage disease type Ia
    Martens, Danielle H. J.
    Rake, Jan Peter
    Schwarz, Martin
    Ullrich, Kurt
    Weinstein, David A.
    Merkel, Martin
    Sauer, Pieter J. J.
    Smit, G. Peter A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (06) : 646.e1 - 646.e7
  • [2] Hepatocellular adenoma in type Ia glycogen storage disease
    Masatoshi Kudo
    Journal of Gastroenterology, 2001, 36 : 65 - 66
  • [3] Liver transplantation for glycogen storage disease type Ia
    Reddy, Srinevas K.
    Austin, Stephanie L.
    Spencer-Manzon, Michele
    Koeberl, Dwight D.
    Clary, Bryan M.
    Desai, Dev M.
    Smith, Alastair D.
    Kishnani, Priya S.
    JOURNAL OF HEPATOLOGY, 2009, 51 (03) : 483 - 490
  • [4] Moyamoya disease in a child with glycogen storage disease type Ia
    Goutieres, F
    Bourgeois, M
    Trioche, P
    Demelier, JF
    Odievre, M
    Labrune, P
    NEUROPEDIATRICS, 1997, 28 (02) : 133 - 134
  • [5] Hepatocellular adenoma in type Ia glycogen storage disease
    Kudo, M
    JOURNAL OF GASTROENTEROLOGY, 2001, 36 (01) : 65 - 66
  • [6] Tubular glycogen nuclei in a patient with glycogen storage disease type Ia
    Liang, Dandan
    Liu, Jing
    Zuo, Ke
    Gao, Erzhi
    Liang, Shaoshan
    Xu, Feng
    Zeng, Caihong
    KIDNEY INTERNATIONAL, 2024, 106 (06) : 1188 - 1188
  • [7] Mutation analysis in glycogen storage disease type Ia
    Meaney, C
    Lee, P
    Cranston, T
    Genet, S
    JOURNAL OF MEDICAL GENETICS, 2000, 37 : S73 - S73
  • [8] Hepatic Adenomas in Type Ia Glycogen Storage Disease
    不详
    GASTROENTEROLOGY, 2008, 135 (06) : 1817 - 1818
  • [9] Frequent hypoglycemia in Glycogen Storage Disease Type Ia
    Jirajariyavej, Teeranun
    Jain, Akshay Bhanwarlal
    Gianoukakis, Andrew George
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [10] A pediatric patient with glycogen storage disease type IA and Castleman disease
    Cuglievan, Branko
    Menegaz, Brian A.
    DePombo, April
    Morani, Ajaykumar C.
    Miranda, Roberto N.
    Rytting, Michael
    PEDIATRIC BLOOD & CANCER, 2017, 64 (08)